[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356591-105":59,"doc-detail-356591-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sirt3-regulates-hmgcs2-deacetylation-and-influences-cholangiocarcinoma-progression-via-the-metabolism-of-ketone-bodies","SIRT3 Regulates HMGCS2 Deacetylation and Influences Cholangiocarcinoma Progression via the Metabolism of Ketone Bodies","","Cholangiocarcinoma (CCA) is a highly aggressive malignancy with unclear roles for key metabolic regulators. This study examines HMGCS2, a mitochondrial ketogenesis enzyme, in CCA using TCGA tissue data, immunoblotting, CCA cell lines, and xenograft models. Functional experiments, metabolomics, and multiple assays assess how SIRT3 deacetylates HMGCS2 at K310 and modulates ketone-body synthesis. Downregulated HMGCS2/SIRT3 correlates with poor survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sirt3-regulates-hmgcs2-deacetylation-and-influences-cholangiocarcinoma-progression-via-the-metabolism-of-ketone-bodies/356591/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sirt3-regulates-hmgcs2-deacetylation-and-influences-cholangiocarcinoma-progression-via-the-metabolism-of-ketone-bodies/356591.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study in CCA research?","Question",{"text":112,"@type":113},"The study focuses on how SIRT3 regulates HMGCS2 deacetylation and how this affects cholangiocarcinoma progression through ketone-body metabolism.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was HMGCS2 investigated in cholangiocarcinoma tissues and models?",{"text":117,"@type":113},"HMGCS2 expression was analyzed using TCGA data and immunoblotting, with functional verification in CCA cell lines and an in vivo xenograft model.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does SIRT3 play in relation to HMGCS2?",{"text":121,"@type":113},"SIRT3 deacetylates HMGCS2 at K310, promoting ketone-body synthesis and suppressing CCA progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356591,1790704961,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Human Mutation  \n SPECIAL ISSUE Decoding the Crosstalk of Immune Microenvironment and Mutational Landscapes in Solid Tumors: From Bench to Bedside  \nRESEARCH ARTICLE  OPEN ACCESS   \nSIRT3 Regulates HMGCS2 Deacetylation and Influences Cholangiocarcinoma Progression via the Metabolism of Ketone Bodies  \nSihua Liu1, 2 | Xiao You1 | Dongdong Wang1 | Xin Wang1 | Yuhang Yang1 | Fangfang Chen1 | Juan Zheng2 | Feiyu Qi1 | Wanliang Sun1 | Wei Peng3 | Jin Xi2 | Zheng Lu1 | Dengyong Zhang1  \n1Department of General Surgery, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China | 2Anhui Key Laboratory of Tissue Transplantation, Bengbu Medical University, Bengbu, Anhui, China | 3Department of General Surgery, The Hospital of Fengyang County, Chuzhou, China Correspondence: Zheng Lu ([luzhengdr@bbmc.edu.cn](luzhengdr@bbmc.edu.cn)) | Dengyong Zhang ([zhangdengyongdr@163.com](zhangdengyongdr@163.com))  \nReceived: 26 December 2025 | Revised: 5 March 2026 | Accepted: 13 March 2026  \nGuest Editor: Run Shi  \nKeywords: acetylation | cholangiocarcinoma | HMGCS2 | ketone bodies | mutation | SIRT3  \nABSTRACT  \nCholangiocarcinoma (CCA) is a highly aggressive malignancy. 3-Hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), a mitochondrial enzyme involved in ketogenesis, has been linked to tumor progression, but its role in CCA remains unclear. HMGCS2 expression in CCA tissues was analyzed using TCGA data and immunoblotting (IB) . Functional assays were performed in CCA cell lines (HuCCT-1 and RBE) and an in vivo xenograft model. Metabolomics explored HMGCS2-mediated metabolic changes. SIRT3–HMGCS2 interactions were examined via molecular docking, IF, CO-IP, GST pull-down, and CHX assays, with mutational analysis identifying interaction sites. IHC assessed clinical samples. HMGCS2 was downregulated in CCA. Overexpression inhibited proliferation and invasion, while knockdown promoted these effects, consistent in vitro and in vivo. Metabolomics showed HMGCS2 enhanced ketone body synthesis, and exogenous ketone bodies mimicked its antitumor effects. SIRT3 deacetylated HMGCS2 at K310 (with plasmid mutation assay), and low HMGCS2/SIRT3 expression correlated with poor patient survival. SIRT3-mediated deacetylation of HMGCS2 promotes ketone body synthesis, suppressing CCA progression. HMGCS2 is a potential therapeutic target for CCA.  \n1 | Introduction  \nCholangiocarcinoma (CCA), a rare and highly heterogeneous malignant tumor originating from the bile duct epithelium, not only presents with limited obvious symptoms in the early stages but also lacks an effective diagnostic marker. Owing to its highly invasive nature, CCA has been associated with late patient diagnoses, lack of effective treatments, and a poor prognosis despite radiotherapy (RT) and chemotherapy, with a 5-year survival rate (SR) of only 7%–20%[1–3] . Energy metabolism variations between normal and cancer cells have recently provided novel therapeutic insights [4, 5] . Tumor cells undergo metabolic reprogramming to meet the energy demands for rapid proliferation,  \nas evidenced by increased glycolysis and fatty acid metabolism. In this regard, it is noteworthy that ketone bodies are fatty acid metabolites and that their relationship with tumor progression is well documented [6] . For instance, ketone bodies induced metabolic changes in pancreatic cancer cells, inhibiting tumor growth and inducing apoptosis [7] . This phenomenon highlights the significance of a deeper understanding of the targetsand roles of metabolic reprogramming in tumor progression. In other words, it could provide novel therapeutic insights into CCA management.  \nThe 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) enzyme, a member of the HMG-CoA synthase family, functions  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nCopyright © 2026 Sihua ","cbCaiooHcjzLpSdW","https://ap.wps.com/l/cbCaiooHcjzLpSdW","pdf",4260626,14,"English","# Introduction\n## Background on cholangiocarcinoma and metabolic reprogramming\n## HMGCS2 in ketogenic reactions and cancer contexts\n## SIRT3 as a mitochondrial deacetylase and relevance to CCA","[{\"question\":\"What is the main focus of the study in CCA research?\",\"answer\":\"The study focuses on how SIRT3 regulates HMGCS2 deacetylation and how this affects cholangiocarcinoma progression through ketone-body metabolism.\"},{\"question\":\"How was HMGCS2 investigated in cholangiocarcinoma tissues and models?\",\"answer\":\"HMGCS2 expression was analyzed using TCGA data and immunoblotting, with functional verification in CCA cell lines and an in vivo xenograft model.\"},{\"question\":\"What role does SIRT3 play in relation to HMGCS2?\",\"answer\":\"SIRT3 deacetylates HMGCS2 at K310, promoting ketone-body synthesis and suppressing CCA progression.\"}]","SIRT3 Regulates HMGCS2 Deacetylation and Influences Cholangiocarcinoma Progression via the Metabolism of Ketone Bodies | PDF",1790126102,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb63c97318b6a797397d967b2d1f12b0.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/37021e8b298db34cfe0e3db93fa92410.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f5f3350ff449c574aa4f7bba5a86bdf.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/070d5202202d67708e4bdd85cffe6ece.webp",980,1287]